This Article
Right arrow Full Text (PDF) Free
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCollough, W. M.
Right arrow Articles by Heare, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCollough, W. M.
Right arrow Articles by Heare, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Facebook   Add to Technorati   Add to Twitter  
What's this?

The Journal of Bone and Joint Surgery, Vol 73, Issue 5 717-725, Copyright © 1991 by Journal of Bone and Joint Surgery, Inc


JOURNAL CONTENTS

Radiation therapy for aggressive fibromatosis. The Experience at the University of Florida

WM McCollough, JT Parsons, R van der Griend, WF Enneking and T Heare
Department of Radiation Oncology, University of Florida College of Medicine, Gainesville.

Twenty-nine patients (thirty sites) who had histologically confirmed aggressive fibromatosis were treated with radical courses of radiation at the University of Florida between March 1975 and February 1986. The minimum length of follow-up was two years; 76 per cent of the patients were followed for more than five years. Twenty-seven sites received doses of at least 5000 centigrays (one centigray equals one rad). Twelve patients were treated twice a day. Fourteen sites were treated with radiation postoperatively for known or presumed microscopic quantities of residual aggressive fibromatosis; in eleven, the disease was locally controlled. Sixteen sites were treated postoperatively for known grossly apparent residual disease; in fourteen, the disease was locally controlled. Over-all, aggressive fibromatosis was controlled in twenty-five (83 per cent) of the thirty sites. The six-year actuarial rate of local control was 79 per cent. The five local recurrences occurred at four, eleven, thirty-four, sixty-one, and sixty-eight months after the initiation of radiation therapy. Two of the five failures occurred in the high-dose radiation field in patients who were treated for grossly apparent disease. The remaining three failures occurred at the margin of the irradiated field in patients who were treated for assumed microscopic quantities of residual disease. There was no apparent difference in local control between patients who were treated for primary (previously untreated) aggressive fibromatosis and those who were treated after one or more recurrences. Comparison of the results of radiation therapy with published data on operative treatment shows that local control substantially improves with postoperative radiation therapy when operative margins are less than wide.(ABSTRACT TRUNCATED AT 250 WORDS)
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Facebook Facebook   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
Y. Ferah, K. Ayse, C. Mustafa, S. Ugur, G. Murat, and A. I. Lale
Possible Therapeutic Role of Vitamin D3 in Aggressive Fibromatosis
Jpn. J. Clin. Oncol., August 1, 2004; 34(8): 472 - 475.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
J. Janinis, M. Patriki, L. Vini, G. Aravantinos, and J. S. Whelan
The pharmacological treatment of aggressive fibromatosis: a systematic review
Ann. Onc., February 1, 2003; 14(2): 181 - 190.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. T. Ballo, G. K. Zagars, A. Pollack, P. W.T. Pisters, and R. A. Pollock
Desmoid Tumor: Prognostic Factors and Outcome After Surgery, Radiation Therapy, or Combined Surgery and Radiation Therapy
J. Clin. Oncol., January 1, 1999; 17(1): 158 - 158.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
M. HAMEED, J. BENEVENIA, M. BLACKSIN, and S. C. AISNER
Nuchal Fibroma of the Shoulder Involving Skeletal Muscle: A Radiographic and Clinicopathological Study. A Case Report
J. Bone Joint Surg. Am., November 1, 1998; 80(11): 1684 - 6.
[Full Text]


Home page
Arch SurgHome page
W.-H. Ng, J. S-Y Lee, W.-T. Poh, and C.-Y. Wong
Desmoid Tumor (Fibromatosis) of the Breast: A Clinician's Dilemma--A Case Report and Review
Arch Surg, April 1, 1997; 132(4): 444 - 446.
[Abstract] [PDF]


Home page
JBJSHome page
D. J. PRITCHARD, A. G. NASCIMENTO, and I. A. PETERSEN
Local Control of Extra-Abdominal Desmoid Tumors*{{dagger}}
J. Bone Joint Surg. Am., June 1, 1996; 78(6): 848 - 54.
[Abstract] [Full Text]